Related Experiment Video
Updated: Apr 25, 2026

05:25
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
19.7K
Phytotherapy of benign prostatic hyperplasia. A minireview
Phytotherapy Research : PTR
|August 29, 2014
Summary
Benign prostate hyperplasia (BPH) affects older men, causing urinary symptoms. This review examines natural remedies like botanicals and nutraceuticals for BPH symptom management and safety.
Area of Science:
- Urology
- Pharmacology
- Natural Products
Background:
- Benign prostate hyperplasia (BPH) is a prevalent condition in aging men, with symptoms like frequent urination and hesitancy.
- BPH incidence increases with age, affecting over 50% of men by 60 and up to 90% by 85.
- Conventional treatments include alpha blockers and 5-alpha reductase inhibitors.
Purpose of the Study:
- To review the efficacy and safety of common botanicals and nutraceuticals for managing BPH-related lower urinary tract symptoms.
- To analyze the mode of action and potential herb-drug interactions of these natural agents.
Main Methods:
- Literature review of scientific articles on botanicals and nutraceuticals for BPH.
- Analysis of studies on Serenoa repens, Pygeum africanum, Urtica dioica, Cucurbita pepo, isoflavones, lycopene, selenium, and beta-Sitosterol.
- Evaluation of efficacy, safety, and herb-drug interaction data.
Main Results:
- Botanicals like Saw palmetto (Serenoa repens) and Pygeum africanum show potential in improving BPH symptoms.
- Nutraceuticals such as beta-Sitosterol and lycopene may offer benefits for lower urinary tract symptoms.
- Safety profiles and potential herb-drug interactions require careful consideration for all natural agents.
Conclusions:
- Botanicals and nutraceuticals represent viable options for managing benign prostate hyperplasia symptoms.
- Further research is needed to fully elucidate the mechanisms, optimize dosages, and confirm long-term safety and efficacy.
- Personalized treatment strategies incorporating natural remedies should consider individual patient profiles and potential interactions.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
608
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
608
Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K

